Targeted Radiopharmaceuticals Summit EU 2024
R&D
As radiopharmaceutical innovation flourishes and collaboration continues with even more recent billion-dollar deals from Novartis and Eli Lilly, we are thrilled to bring back the longest-standing industry-dedicated meeting, 6th Targeted Radiopharmaceuticals Summit Europe, taking place in Amsterdam 3rd- 5th December!
With 40+ new speakers, 2 tracks of content (pre-clinical and clinical), a deep dive workshop day, and 140+ attendees – this summit is set to deliver an end-to-end overview of this highly competitive and dynamic landscape:
- Unearthing novel targets for radiopharmaceuticals from ACP3m, AVB6, AVB8, and PDL-1 with Philochem, TRIMT, Fusion-AstraZeneca, and Mariana-Novartis while revealing cutting-edge targeting moieties for enhanced specificity and efficacy from Starget Pharma and Star Pharma
- Interrogating isotope comparison data to understand the optimal blend of biological half-life, physical half-life, and targeting moiety while exploring immune profiles stimulated with OranoMed and Ariceum
- Assessing dosimetry regulatory guidelines and exploring exactly how they should be implemented into the clinic for enhanced patient safety and efficacy with Bayer, Lund University, Institute of Cancer Research, and more
- Turbocharging your manufacturing safety, quality, and efficiency by exploring novel isolation technologies and new processes with ARTBIO and RadioPharm Theranostics and measuring alphas in the clinic
Check out the full session details here with over 40+ expert speakers.
You can register your place here while discounts last and take advantage of group discounts of up to 20% when you bring your colleagues.
